2.8 Å resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity

Immunity

Volumn 11, Issue 2, 1999, Pages 253-261

  Cha, Sun Shin ^a   Kim, Min Sung ^a   Choi, Yo Han ^a   Sung, Byung Je ^a   Shin, Nam Kyu ^b   Shin, Hang Cheol ^b   Sung, Young Chul ^a   Oh, Byung Ha ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Hanhyo Institute of Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIGAND; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; LEUKOCYTE ANTIGEN; LYMPHOTOXIN; MEMBRANE PROTEIN; TNFRSF10A PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER IMMUNOLOGY; CRYSTAL STRUCTURE; CYTOTOXICITY; HUMAN; LEUKEMIA CELL LINE; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; AMINO ACID SEQUENCE; BINDING SITE; CHEMISTRY; CRYSTALLOGRAPHY; METABOLISM; MOLECULAR GENETICS; MUTATION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; CRYSTALLOGRAPHY; HUMANS; LYMPHOTOXIN-ALPHA; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; STRUCTURE-ACTIVITY RELATIONSHIP; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033169230     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80100-4     Document Type: Article

References (36)

1. Banner, D.W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.J., Broger, C., Loetscher, H., and Lesslauer, W. (1993). Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: Implications for TNF receptor activation. Cell 73, 431-445.
2. Bazan, J.F. (1993). Emerging families of cytokines and receptors. Curr. Biol. 3, 603-606.
3. Brünger, A.T. (1992). X-PLOR Version 3.0 (New Haven, CT.: Yale University Press).
4. Cha, S.-S., Shin, H.-C., Choi, K.W., and Oh, B.-H. (1999). Expression, purification, and crystallization of recombinant human TRAIL. Acta Crystallogr. D 55, 1101-1104.
5. Collaborative Computational Project Number (1994). The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D 50, 760-763.
6. Corti, A., Fassina, G., Marcucci, F., Barbanti, E., and Cassani, G. (1992). Oligomeric tumor necrosis factor a slowly converts into inactive forms at biological levels. Biochem. J. 284, 905-910.
7. Cosman, D. (1994). A family of ligands for the TNF receptor superfamily. Stem Cells 12, 440-455.
8. Creasey, A.A., Doyle, L.V., Reynolds, T., Jung, T., Lin, L.S., and Vitt, C.R. (1987). Biological effects of recombinant human tumor necrosis factors and its novel muteins on tumor and normal cell lines. Cancer Res. 47, 145-149.
9. Eck, M.J., and Sprang, S.R. (1989). The structure of tumor necrosis factor-alpha at 2.6 å resolution. Implications for receptor binding. J. Biol. Chem. 264, 17595-17605.
10. Eck, M.J., Ultsch, M., Rinderknecht, E., de Vos, A.M., and Sprang, S.R. (1992). The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-å resolution. J. Biol. Chem. 267, 2119-2122.
11. Emery, J.G., McDonnell, P., Burke, M.B., Deen, K.C., Lyn, S., SilVerman, C., Dul, E., Appelbaum, E.R., Eichman, C., DiPrinzio, R., et al. (1998). Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273, 14363-14367.
12. Esnouf, R.M. (1997). An extensively modified version of molscript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15, 132-134.
13. Griffith, T.S., and Lynch, D.H. (1998). TRAIL: A molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 10, 559-563.
14. Griffith, T.S., Wiley, S.R., Kubin, M.Z., Sedger, L.M., Maliszewski, C.R., and Fanger, N.A. (1999). Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J. Exp. Med. 189, 1343-1354.
15. Honig, B., and Nicholls, A. (1995). Classical electrostatics in biology and chemistry. Science 268, 1144-1149.
16. Jones, T.A., and Kjeldgaard, M. (1993). O version 5.9 (Uppsala, Sweden: Uppsala University).
17. Jones, E.Y., Stuart, D.I., and Walker, N.P. (1989). Structure of tumour necrosis factor. Nature 338, 225-228.
18. Kagan, B.L., Baldwin, R.L., Munoz, D., and Wisnieski, B.J. (1992). Formation of ion-permeable channels by tumor necrosis factor-alpha. Science 255, 1427-1430.
19. Karpusas, M., Hsu, Y.-M., Wang, J., Thompson, J., Lederman, S., Chess, L., and Thomas, D. (1995). 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3, 1031-1039.
20. Kayagaki, N., Yamaguchi, N., Nakayama, M., Kawasaki, A., Akiba, H., Okumura, K., and Yagita, H. (1999). Involvement of TNF-related apoptosis-inducing ligand in human CD40+ cell-mediated cytotoxicity. J. Immunol. 162, 2639-2647.
21. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
22. Lotz, M., Setareh, M., Kempis, J., and Schwarz, H. (1996). The nerve growth factor/tumor necrosis factor receptor family. J. Leuk. Biol. 60, 1-7.
23. Marsters, S.A., Sheridan, J.P., Pitti, R.M., Huang, A., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A.D., Godowski, P., et al. (1997). A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7, 1003-1006.
24. Mongkolsapaya, J., Cowper, A.E., Xu, X.N., Morris, G., McMichael, A.J., Bell, J.I., and Screaton, G.R. (1998). Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): A new receptor protecting lymphocytes from the death ligand TRAIL. J. Immunol. 160, 3-6.
25. Nagata, S., and Golstein, P. (1995). The fas death factor. Science 267, 1449-1456.
26. Naismith, J.H., Devine, T.Q., Kohno, T., and Sprang, S.R. (1996). Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 4, 1251-1262.
27. Pan, G., O'Rourke, K., Chinnaiyan, A.M., Gentz, R., Ebner, R., Ni, J., and Dixit, V.M. (1997a). The receptor for the cytotoxic ligand TRAIL. Science 276, 111-113.
28. Pan, G., Ni, J., Wei, Y.F., Yu, G., Gentz, R., and Dixit, V.M. (1997b). An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-818.
29. Peitsch, M.C. (1996). Promod and swiss-model: Internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24, 274-279.
30. Pitti, R.M., Marsters, S.A., Ruppert, S., Donahue, C.J., Moore, A., and Ashkenazi, A. (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687-12690.
31. Sheridan, J.P., Marsters, S.A., Pitti, R.M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C.L., Baker, K., Wood, W.I., et al. (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818-821.
32. Singh, J., Garber, E., van Vlijmen, V., Karpusas, M., Hsu, Y.-M., Zheng, Z., Naismith, J.H., and Thomas, D. (1998). The role of polar interactions in the molecular recognition of CD40L with its receptor CD40L. Protein Sci. 7, 1124-1135.
33. Smith, C.A., Farrah, T., and Goodwin, R.G. (1994). The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76, 959-962.
34. van Ostade, X., Tavernier, J., and Fiers, W. (1994). Structure-activity studies of human tumour necrosis factors. Protein Eng. 7, 5-22.
35. Walczak, H., Miller, R.E., Ariail, K., Gliniak, B., Griffith, T.S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5, 157-163.
36. Wiley, S.R., Schooley, K., Smolak, P.J., Din, W.S., Huang, C.P., NiCholl, J.K., Sutherland, G.R., Smith, T.D., Rauch, C., Smith, C.A., et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682.